NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 120 filers reported holding NURIX THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $110,622 | -21.3% | 14,074 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $140,599 | +12.5% | 14,074 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $124,977 | -19.1% | 14,074 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $154,533 | -15.6% | 14,074 | 0.0% | 0.00% | -25.0% |
| Q3 2022 | $183,000 | +34.6% | 14,074 | +31.3% | 0.00% | +33.3% |
| Q2 2022 | $136,000 | -9.3% | 10,717 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $150,000 | -47.6% | 10,717 | +8.7% | 0.00% | -40.0% |
| Q4 2021 | $286,000 | +43.0% | 9,862 | +47.6% | 0.01% | +25.0% |
| Q3 2021 | $200,000 | – | 6,680 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 4,508,333 | $140,164,000 | 17.73% |
| Ponoi II Management, LLC | 686,274 | $21,336,000 | 16.34% |
| Column Group LLC | 5,383,333 | $167,368,000 | 16.04% |
| Ponoi Management, LLC | 686,274 | $21,336,000 | 12.55% |
| Foresite Capital Management IV, LLC | 1,238,456 | $38,504,000 | 4.61% |
| Foresite Capital Management V, LLC | 451,522 | $14,038,000 | 4.13% |
| WestHill Financial Advisors, Inc. | 283,333 | $8,809,000 | 3.13% |
| EcoR1 Capital, LLC | 2,019,019 | $62,771,000 | 2.78% |
| Bain Capital Life Sciences Investors, LLC | 1,284,314 | $39,929,000 | 2.26% |
| DAFNA Capital Management LLC | 306,320 | $9,523,000 | 2.26% |